NUTX Nutex Health Inc

Price (delayed)

$0.64

Market cap

$31.8M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.05

Enterprise value

$285.56M

nutex health is a consortium of licensed 24/7 free standing emergency centers. our philosophy is simple: bring concierge level, high quality emergency care to the local community. we build the ...

Highlights

Nutex Health's gross profit has surged by 125% YoY and by 91% QoQ

The company's gross margin has surged by 100% YoY and by 77% QoQ

NUTX's EPS has soared by 90% YoY but it is down by 40% QoQ

The net income has soared by 89% year-on-year but it has dropped by 58% since the previous quarter

NUTX's equity is down by 36% YoY and by 32% from the previous quarter

Sector: Healthcare

Industry: Health Information Services

Peers: SEM NVOS

Key stats

What are the main financial stats of NUTX

Market

Shares outstanding

49.7M

Market cap

$31.8M

Enterprise value

$285.56M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

0.47

Price to sales (P/S)

0.12

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

1.15

Earnings

Revenue

$247.65M

EBIT

-$34.54M

EBITDA

-$16.81M

Free cash flow

-$8.24M

Per share

EPS

-$1.05

Free cash flow per share

-$0.18

Book value per share

$1.37

Revenue per share

$5.54

TBVPS

$8.07

Balance sheet

Total assets

$398.25M

Total liabilities

$319.14M

Debt

$275.76M

Equity

$61.45M

Working capital

$32.54M

Liquidity

Debt to equity

4.49

Current ratio

1.56

Quick ratio

1.45

Net debt/EBITDA

-15.09

Margins

EBITDA margin

-6.8%

Gross margin

14%

Net margin

-18.5%

Operating margin

-12.8%

Efficiency

Return on assets

-10.5%

Return on equity

-54.4%

Return on invested capital

-5.7%

Return on capital employed

-10.2%

Return on sales

-13.9%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

NUTX stock price

How has the Nutex Health stock price performed over time

Intraday

4.92%

1 week

-1.54%

1 month

-54.42%

1 year

-91.24%

YTD

-76.3%

QTD

-55.51%

Financial performance

How have Nutex Health's revenue and profit performed over time

Revenue

$247.65M

Gross profit

$34.77M

Operating income

-$31.77M

Net income

-$45.79M

Gross margin

14%

Net margin

-18.5%

NUTX's operating income has dropped by 173% since the previous quarter but it has surged by 92% year-on-year

Nutex Health's operating margin has shrunk by 156% QoQ but it has surged by 93% YoY

Nutex Health's gross profit has surged by 125% YoY and by 91% QoQ

The company's gross margin has surged by 100% YoY and by 77% QoQ

Growth

What is Nutex Health's growth rate over time

Valuation

What is Nutex Health stock price valuation

P/E

N/A

P/B

0.47

P/S

0.12

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

1.15

NUTX's EPS has soared by 90% YoY but it is down by 40% QoQ

The P/B is 87% below the 5-year quarterly average of 3.6 and 86% below the last 4 quarters average of 3.4

NUTX's equity is down by 36% YoY and by 32% from the previous quarter

The stock's price to sales (P/S) is 96% less than its 5-year quarterly average of 2.9 and 92% less than its last 4 quarters average of 1.5

The revenue is up by 13% year-on-year and by 7% since the previous quarter

Efficiency

How efficient is Nutex Health business performance

Nutex Health's ROIC has plunged by 148% from the previous quarter but it has soared by 94% YoY

NUTX's ROS has shrunk by 128% QoQ but it has soared by 92% YoY

NUTX's ROA has soared by 89% YoY but it has plunged by 62% from the previous quarter

Nutex Health's return on equity has shrunk by 74% QoQ but it has surged by 74% YoY

Dividends

What is NUTX's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for NUTX.

Financial health

How did Nutex Health financials performed over time

The total assets is 25% greater than the total liabilities

The company's quick ratio rose by 20% QoQ but it fell by 14% YoY

The total assets has declined by 17% since the previous quarter and by 8% year-on-year

The debt to equity has soared by 61% YoY and by 23% from the previous quarter

NUTX's equity is down by 36% YoY and by 32% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.